The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Alteration Earth PLC

21 Oct 2021 07:00

RNS Number : 7420P
Primorus Investments PLC
21 October 2021
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Investment in Alteration Earth PLC

 

Primorus Investments plc (AIM: PRIM) is pleased to announce it has agreed to invest up to £350,000 in Alteration Earth PLC ("ALTE"), a recently established special purpose acquisition company ("SPAC") (the "Investment").

 

The Investment is being made in two parts, a seed round (the "Seed Round") and a subscription round (the "Subscription Round"). The Seed Round will be funded at 4p per ordinary share and the Subscription Round will be funded at 10p per ordinary share. Assuming both rounds are fully subscribed, Primorus will hold 5,000,000 ordinary shares as follows:

· 2,500,000 shares at 4p per share in the seed round (for a total of £100,000); and

· 2,500,000 shares at 10p per share in the subscription round (for a total of £250,000).

 

The Investment will represent an approximate ownership of 28% of the issued share capital of ALTE assuming both the Seed Round and Subscription Round are fully subscribed.

 

The Subscription Round is conditional on the admission of ALTE's share capital to the Standard Segment of the Main Market of the London Stock Exchange on or before 31 December 2021 ("Admission"). The subscription monies will be held in escrow on behalf of the investors until such time as Admission takes place, or will be returned to the investors if Admission does not take place before 31 December 2021.

 

In addition to the above, Primorus has been granted 1,800,000 warrants to subscribe for new ordinary shares in ALTE, with a strike price at par value (0.1p), at any time up to the fifth anniversary of the date of grant. The warrants have been awarded to Primorus because it has agreed to underwrite the cost, up to a maximum of £150,000, of ALTE obtaining Admission as described above.

 

If Admission does not occur by 31 December 2021, the Subscription Round will not proceed, and all Subscription Round funds delivered by Primorus pursuant to this agreement will be returned to it, without interest, less the costs incurred by ALTE pursuant to the listing up to a maximum of £150,000.

 

About ALTE

 

ALTE is seeking to list on the Standard Segment of the Main Market of the London Stock Exchange on or before 31 December 2021. ALTE has been created as SPAC with a focus on clean technology and clean energy investments.

 

ALTE has formed a partnership with the strategic and financial advisory firm Gneiss Energy (https://gneiss.energy/) to ensure it maximises its prospects of finding the most value-accretive acquisition for its shareholders. Gneiss has an extensive track record within the energy and clean technology sector. Gneiss has a dedicated team that specialises in mergers and acquisitions and this expertise will be leveraged to search for and recommend assets to ALTE. Gneiss will carry out the screening and detailed due diligence on the potential assets which will ensure a high level of professional due diligence is completed and in turn maximising the chances of ALTE acquiring a strong performing and commercially viable asset.

 

ALTE is seeking to raise a total of £1,260,000 for its proposed listing. This amount will be allocated as follows:

· 9,000,000 shares at 4p (Seed Round); and

· 9,000,000 shares at 10p (Subscription Round).

 

ALTE has stated that it will consider any investment that presents itself within the clean technology and/or clean energy sector; however, the management team will give priority to the following:

¡ Hydrogen production and technology

¡ Waste to energy

¡ Repurposing and recycling businesses and technology

¡ Infrastructure, construction and building technology

¡ Energy storage and deployment technology

¡ Renewable energy

 

Matthew Beardmore has joined the board of ALTE as a non-executive director for the purposes of monitoring the Primorus investment.

 

In addition to Primorus making its investment into ALTE, Matthew Beardmore, Rupert Labrum and Simon Holden have agreed to invest in ALTE as follows:

· Matthew Beardmore has agreed to invest £28,000 (approximately 2% of the issued share capital) based on 200,000 shares at 4p and 200,000 shares at 10p;

· Matthew Beardmore has also been awarded 450,000 warrants to subscribe for new ordinary shares with a strike price at par value (0.1p);

· Simon Holden has agreed to invest £28,000 (approximately 2% of the issued share capital) based on 200,000 shares at 4p and 200,000 shares at 10p; and

· Rupert Labrum has agreed to invest £252,000 (representing 20% of the issued share capital) based on 1,800,000 shares at 4p and 1,800,000 shares at 10p.

 

Related Party Transaction

 

 

Matthew Beardmore was one of two subscriber shareholders, and currently holds one of the two shares, in ALTE, and therefore the Investment is deemed under the AIM Rules for Companies to be a related party transaction. In addition, Simon Holden, company secretary of the Company, subscribed for the other founder share.

 

The independent directors, being Rupert Labrum and Hedley Clark, consider, having consulted with Cairn Financial Advisers LLP, the nominated adviser to the Company, that the terms of the Investment are fair and reasonable insofar as its shareholders are concerned.

 

 

Rupert Labrum, Executive Chairman of Primorus, commented: "We believe the opportunity to participate early in the evolution of ALTE and particularly in this area of the market represents a significant opportunity to add tangible value for Primorus shareholders. ALTE has targeted an area of the market that we believe is going to see exponential growth over the coming years as the world transitions into cleaner forms of energy."

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

 

+44 (0) 20 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFSLIILIFIL
Date   Source Headline
15th Apr 20247:00 amRNSInvestee Company Update – Engage Technology
25th Mar 20247:00 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSHolding(s) in Company
19th Mar 20242:45 pmRNSFurther re Dividend Declaration
11th Mar 20244:51 pmRNSDividend Declaration
8th Mar 202411:49 amRNSFurther Investment in Fresho Pty Ltd
27th Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSInvestee Company Update – Payapps Limited
2nd Feb 20243:26 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSInvestee Company Update – Payapps Limited
11th Oct 20239:59 amRNSDirector/PDMR Shareholding
28th Sep 20235:27 pmRNSDirector/PDMR Shareholding
19th Sep 20234:50 pmRNSHolding(s) in Company
15th Sep 20237:41 amRNSFurther re Investment in Interpac & Bushveld CLN
18th Aug 20233:12 pmRNSHalf-year Report
15th Aug 202312:06 pmRNSResult of AGM
2nd Aug 202310:25 amRNSAlteration Earth - Investment Update
20th Jul 20237:00 amRNSNotice of AGM
14th Jul 20234:00 pmRNSBushveld Convertible Loan Note Update
20th Jun 20237:00 amRNSConsent to Electronic Communication
16th Jun 20233:18 pmRNSFinal Results
16th Mar 20232:50 pmRNSDirector/PDMR Shareholding
19th Jan 20233:25 pmRNSHolding(s) in Company
19th Jan 20233:23 pmRNSDirector/PDMR Shareholding
8th Dec 20227:01 amRNSHolding(s) in Company
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:05 amRNSSecond Price Monitoring Extn
29th Nov 202211:00 amRNSPrice Monitoring Extension
13th Sep 20223:50 pmRNSInvestment in Interpac Ltd
2nd Sep 20222:00 pmRNSHalf-year Report
1st Jul 20228:23 amRNSInvestment Update
30th Jun 202210:43 amRNSResult of AGM
10th Jun 20223:00 pmRNSFinal Results
6th Jun 202211:39 amRNSUpdate on Alteration Earth PLC Investment
31st May 20223:58 pmRNSNotice of AGM
4th May 202212:33 pmRNSUpdate on Alteration Earth PLC Investment
5th Apr 20227:00 amRNSUpdate on Alteration Earth PLC Investment
30th Mar 20228:12 amRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFurther re Investment in Mustang
17th Mar 20224:12 pmRNSFurther Investment in Rambler Metals & Mining PLC
16th Mar 20221:05 pmRNSCancellation of Share Options
8th Mar 202210:48 amRNSUpdate on Alteration Earth PLC Investment
28th Feb 20224:45 pmRNSFurther re Investment in Mustang
16th Feb 20227:00 amRNSGeneral Update & Clean Power Hydrogen Investment
3rd Feb 20227:00 amRNSInvestment in Rambler Metals & Mining PLC
31st Jan 202210:54 amRNSAlteration Earth Update
19th Jan 20228:01 amRNSFurther re Investment in Mustang
24th Dec 202110:11 amRNSAlteration Earth update
21st Dec 20217:00 amRNSUpdate on Mustang Energy Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.